Drugs / Oncovir poly IC:LC
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01008527 Background | Oct 2009 → Sep 2013 | melanoma | H. Lee Moffitt Cancer Center and Research Institute | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oncovir poly IC:LC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01008527 ↗ |
| Route | Subcutaneous | “The injection of 1000 mcg will be made deeply subcutaneously into the same limb as the peptides/Montanide ISA 51 VG” NCT01008527 ↗ |